Evidence map›Paper›PMID 42136797›Full record

ArticleTherapeutic advances in drug safety2026

Increasing risk of hemorrhage following concurrent use of

Jian-An Liao, Teng-Chou Chen, Pony Yee Chee Chai, Tien-Hsing Chen, Yung-Chih Chen

Abstract read
In one paragraph

Article in Therapeutic advances in drug safety, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Jian-An LiaoDepartment of Traditional Chinese Medicine, Keelung Chang Gung Memorial Hospital, Keelung, Taiwan, Republic of China.ORCID https://orcid.org/0000-0003-0458-750X
Teng-Chou ChenDepartment of Pharmacy, School of Pharmaceutical Sciences, National Yang Ming Chiao Tung University, Taipei, Taiwan, Republic of China.ORCID https://orcid.org/0000-0002-9491-0421
Pony Yee Chee ChaiDepartment of Pharmacy, Keelung Chang Gung Memorial Hospital, Keelung, Taiwan, Republic of China.
Tien-Hsing ChenDepartment of Cardiology, Keelung Chang Gung Memorial Hospital, Keelung, Taiwan, Republic of China.
Yung-Chih ChenDivision of General Internal Medicine, Department of Internal Medicine, Keelung Chang Gung Memorial Hospital, No. 222, Maijin Road, Anle District, Keelung 20401, Taiwan, Republic of China.ORCID https://orcid.org/0000-0002-5980-6960

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: There has been a growing trend of combining traditional Chinese medicine and Western medicine, but the safety of co-prescribing Objectives: This study aimed to evaluate the bleeding risk following the concurrent prescribing of Design: A self-controlled case series study was conducted. Methods: This study used the Chang Gung Research Database to identify adult patients co-prescribed oral anticoagulants and Results: Among 525 patients receiving both medications, 146 experienced bleeding events. The risk of any bleeding increased significantly during days 1-14 (aIRR: 3.98; 95% CI: 3.29-4.77) and days 15-28 (aIRR: 3.99; 95% CI: 3.23-4.79) after concurrent prescribing of Conclusion: Concurrent use of

Indexed as

anticoagulantsbleeding riskdrug interactionsSalvia miltiorrhizaself-controlled case series studytraditional Chinese medicine

Identifiers

PMID42136797
PMCPMC13169102

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.